{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T09:58:56Z","timestamp":1785491936752,"version":"3.56.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013290","name":"National Key Research and Development Program of China Stem Cell and Translational Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013290","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Western Pacific"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.lanwpc.2026.101907","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T14:56:48Z","timestamp":1782745008000},"page":"101907","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Comparison of sitafloxacin monotherapy versus doxycycline plus rifampicin for acute uncomplicated human brucellosis: a multicenter, randomized, open-label, non-inferiority trial"],"prefix":"10.1016","volume":"72","author":[{"given":"Chunmei","family":"Qu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingqing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minhe","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongrong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijiao","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianhui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nannan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4584-3859","authenticated-orcid":false,"given":"Gang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.lanwpc.2026.101907_bib1","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.3201\/eid2909.230052","article-title":"Global estimate of human brucellosis incidence","volume":"29","author":"Laine","year":"2023","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"10.1016\/j.lanwpc.2026.101907_bib2","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2023.2290839","article-title":"Long ignored but making a comeback: a worldwide epidemiological evolution of human brucellosis","volume":"13","author":"Liu","year":"2024","journal-title":"Emerg Microbes Infect"},{"issue":"1","key":"10.1016\/j.lanwpc.2026.101907_bib3","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s40249-025-01335-3","article-title":"Zoonotic diseases in China: epidemiological trends, incidence forecasting, and comparative analysis between real-world surveillance data and Global Burden of Disease 2021 estimates","volume":"14","author":"Zhang","year":"2025","journal-title":"Infect Dis Poverty"},{"issue":"2","key":"10.1016\/j.lanwpc.2026.101907_bib4","doi-asserted-by":"crossref","DOI":"10.1080\/07853890.2023.2295398","article-title":"Brucellosis: epidemiology, pathogenesis, diagnosis and treatment-a comprehensive review","volume":"55","author":"Qureshi","year":"2023","journal-title":"Ann Med"},{"key":"10.1016\/j.lanwpc.2026.101907_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.mib.2024.102427","article-title":"The 'ins and outs' of Brucella intracellular journey","volume":"78","author":"Marchesini","year":"2024","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.lanwpc.2026.101907_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1129172","article-title":"The mechanism of chronic intracellular infection with Brucella spp","volume":"13","author":"Guo","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"issue":"7","key":"10.1016\/j.lanwpc.2026.101907_bib7","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.3390\/ijms22073673","article-title":"The mechanism of facultative intracellular parasitism of Brucella","volume":"22","author":"Jiao","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.lanwpc.2026.101907_bib8","doi-asserted-by":"crossref","DOI":"10.1155\/2024\/7992287","article-title":"The economic burden of brucellosis care in China: socioeconomic status inequality","volume":"2024","author":"He","year":"2024","journal-title":"J Trop Med"},{"key":"10.1016\/j.lanwpc.2026.101907_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.actatropica.2025.107556","article-title":"Disease burden of brucellosis among the elderly in Inner Mongolia, China: a cross-sectional data study from 2016 to 2020","volume":"263","author":"Wu","year":"2025","journal-title":"Acta Trop"},{"issue":"4","key":"10.1016\/j.lanwpc.2026.101907_bib10","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3325\/cmj.2010.51.327","article-title":"Human brucellosis in Macedonia - 10 years of clinical experience in endemic region","volume":"51","author":"Bosilkovski","year":"2010","journal-title":"Croat Med J"},{"issue":"Suppl 1","key":"10.1016\/j.lanwpc.2026.101907_bib11","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/j.ijantimicag.2010.06.015","article-title":"Update on brucellosis: therapeutic challenges","volume":"36","author":"Solera","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.lanwpc.2026.101907_bib12","first-page":"1","article-title":"Joint FAO\/WHO expert committee on brucellosis","volume":"740","year":"1986","journal-title":"World Health Organ Tech Rep Ser"},{"issue":"5","key":"10.1016\/j.lanwpc.2026.101907_bib13","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s15010-021-01586-w","article-title":"The current therapeutical strategies in human brucellosis","volume":"49","author":"Bosilkovski","year":"2021","journal-title":"Infection"},{"issue":"12","key":"10.1016\/j.lanwpc.2026.101907_bib14","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1128\/AAC.38.12.2798","article-title":"Possible implications of doxycycline-rifampin interaction for treatment of brucellosis","volume":"38","author":"Colmenero","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.lanwpc.2026.101907_bib15","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/jac\/23.3.433","article-title":"Comparison of three different regimens in the treatment of acute brucellosis: a multicenter multinational study","volume":"23","author":"Acocella","year":"1990","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"10.1016\/j.lanwpc.2026.101907_bib16","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1046\/j.1440-1843.2001.00344.x","article-title":"Progressive rise of Mycobacteriumtuberculosis resistance to rifampicin and streptomycin in Riyadh, Saudi Arabia","volume":"6","author":"Al-Hajjaj","year":"2001","journal-title":"Respirology"},{"issue":"11","key":"10.1016\/j.lanwpc.2026.101907_bib17","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.3390\/ph17111537","article-title":"Antibacterial mechanisms and clinical impact of sitafloxacin","volume":"17","author":"Kuhn","year":"2024","journal-title":"Pharmaceuticals (Basel)"},{"issue":"1","key":"10.1016\/j.lanwpc.2026.101907_bib18","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1128\/AAC.43.1.194","article-title":"In vitro activities of six new fluoroquinolones against Brucella melitensis","volume":"43","author":"Trujillano-Mart\u00edn","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"10.1016\/j.lanwpc.2026.101907_bib19","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1128\/AAC.37.9.1831","article-title":"Quinolones in treatment of human brucellosis: comparative trial of ofloxacin-rifampin versus doxycycline-rifampin","volume":"37","author":"Akova","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.lanwpc.2026.101907_bib20","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/s10156-012-0392-9","article-title":"Clinical and microbiological outcomes in treatment of men with non-gonococcal urethritis with a 100-mg twice-daily dose regimen of sitafloxacin","volume":"18","author":"Ito","year":"2012","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.lanwpc.2026.101907_bib21","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.3201\/eid2608.191806","article-title":"Doxycycline and sitafloxacin combination therapy for treating highly resistant Mycoplasma genitalium","volume":"26","author":"Durukan","year":"2020","journal-title":"Emerg Infect Dis"},{"issue":"9","key":"10.1016\/j.lanwpc.2026.101907_bib22","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1128\/AAC.39.9.2061","article-title":"Doxycycline-rifampin versus doxycycline-streptomycin in treatment of human brucellosis due to Brucella melitensis. The GECMEI Group. Grupo de Estudio de Castilla-la Mancha de Enfermedades Infecciosas","volume":"39","author":"Solera","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.lanwpc.2026.101907_bib23","doi-asserted-by":"crossref","first-page":"e247","DOI":"10.1016\/j.ijid.2011.12.003","article-title":"Comparison of doxycycline-streptomycin, doxycycline-rifampin, and ofloxacin-rifampin in the treatment of brucellosis: a randomized clinical trial","volume":"16","author":"Hashemi","year":"2012","journal-title":"Int J Infect Dis"},{"issue":"11","key":"10.1016\/j.lanwpc.2026.101907_bib24","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1007\/s10096-021-04278-3","article-title":"Comparative activities of sitafloxacin against recent clinical isolates in hospitals across China","volume":"40","author":"Wu","year":"2021","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"10","key":"10.1016\/j.lanwpc.2026.101907_bib25","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.3390\/antibiotics10101242","article-title":"Therapeutic potential of sitafloxacin as a new drug candidate for helicobacter eradication in Korea: an in vitro culture-based study","volume":"10","author":"Choi","year":"2021","journal-title":"Antibiotics (Basel)"},{"issue":"3","key":"10.1016\/j.lanwpc.2026.101907_bib26","doi-asserted-by":"crossref","DOI":"10.1128\/Spectrum.01928-21","article-title":"Minimum inhibitory concentrations before and after antibacterial treatment in patients with Mycobacterium abscessus pulmonary disease","volume":"9","author":"Fujiwara","year":"2021","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.lanwpc.2026.101907_bib27","first-page":"731","article-title":"Meta-analysis of the efficacy of the combination of rifampicin and doxycycline in the treatment of human brucellosis","volume":"102","author":"Solera","year":"1994","journal-title":"Med Clin"},{"issue":"3","key":"10.1016\/j.lanwpc.2026.101907_bib28","doi-asserted-by":"crossref","first-page":"804","DOI":"10.3390\/pharmaceutics15030804","article-title":"Overview of side-effects of antibacterial fluoroquinolones: new drugs versus old drugs, a step forward in the safety profile?","volume":"15","author":"Rusu","year":"2023","journal-title":"Pharmaceutics"},{"issue":"3","key":"10.1016\/j.lanwpc.2026.101907_bib29","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3390\/antibiotics9030106","article-title":"Efficacy and safety of sitafloxacin in the treatment of AcuteaBactebial Infeciion: A Meta-mnalysis of Randorized Contrclled Trialt","volume":"9","author":"Chen","year":"2020","journal-title":"Antibiotics (Basel)"},{"issue":"1","key":"10.1016\/j.lanwpc.2026.101907_bib30","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/07853890.2020.1861322","article-title":"A randomized, active-controlled, multicentre clinical trial to evaluate the efficacy and safety of oral sitafloxacin versus levofloxacin in Chinese adults with acute uncomplicated or complicated urinary tract infection","volume":"53","author":"Li","year":"2021","journal-title":"Ann Med"}],"container-title":["The Lancet Regional Health - Western Pacific"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666606526001112?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666606526001112?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T09:18:55Z","timestamp":1785489535000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666606526001112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":30,"alternative-id":["S2666606526001112"],"URL":"https:\/\/doi.org\/10.1016\/j.lanwpc.2026.101907","relation":{},"ISSN":["2666-6065"],"issn-type":[{"value":"2666-6065","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of sitafloxacin monotherapy versus doxycycline plus rifampicin for acute uncomplicated human brucellosis: a multicenter, randomized, open-label, non-inferiority trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Western Pacific","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lanwpc.2026.101907","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101907"}}